All In MedTech

Company

Align Technology

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Align Technology is on our public-company list (ticker ALGN). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

ALGN

Nasdaq · ALIGN TECHNOLOGY INC

Public float

$11.1B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$4.03B

Fiscal year ending Dec 31, 2025

Net income

$410M

Fiscal year ending Dec 31, 2025

R&D spending

$370M

Fiscal year ending Dec 31, 2025

Cash

$1.14B

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

70.5M

As of Oct 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$21.7M––
2024–$25.3M––
2023–$26.6M––
2022–$26.1M––
2021–$25.6M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Aug 16, 2009Equity$72.3M$98.6M1Rule 506Form D ↗Aug 31, 2009

Company details

From the company's latest Form D.

Legal name
ALIGN TECHNOLOGY INC
Headquarters
Santa Clara, CA
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Over $100,000,000
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    16 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Align Technology we have 5 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 14 since 2015.

    Search the Clearance Tracker

    11 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT06662279 · 36 participants (planned) · Start Oct 25, 2024 · Primary completion Nov 2025

      Device: Removable Rapid Palatal Expander; Banded Palatal Expander · For: Malocclusions; Narrow Maxilla; Narrow Maxillary Arch and 1 more

      Sites: Laguna Hills, California; Warner Robins, Georgia; Naperville, Illinois · 4 sites in all

    • NCT06651944 · 36 participants (planned) · Start Feb 14, 2024 · Primary completion Dec 31, 2026

      Device: Invisalign® System with mandibular advancement featuring occlusal blocks · For: Class II Malocclusion; Mandibular Advancement; Mandibular Retrognathism and 1 more

      Sites: Richmond, Canada; Saint John, Canada; Brampton, Canada

    • NCT02376829 · 164 participants · Start Mar 2015 · Primary completion Nov 23, 2021

      Device: Invisalign System · For: Malocclusion

      Sites: Scottsdale, Arizona; Rocklin, California; Roseville, California · 10 sites in all

    3 more trials with a free account

    Reports received

    169

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    1

    0.6% of reports

    Injury reports

    168

    99% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230700
    Jan 241900
    Feb 240700
    Mar 240400
    Apr 240700
    May 240600
    Jun 240700
    Jul 240800
    Aug 241700
    Sep 240500
    Oct 2401100
    Nov 240900
    Dec 2401300
    Jan 250900
    Feb 2501200
    Mar 2501400
    Apr 251700
    May 2501500
    Jun 251400
    Jul 251900
    Aug 250900
    Sep 251900
    Oct 2501500
    Nov 2502000
    Dec 2512600
    Jan 2601400
    Feb 2602000
    Mar 2601000
    Apr 2601000
    May 260700
    Jun 2601200
    Jul 2601700
    Aug 260800
    Sep 2601000
    Oct 2601400
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.